Villy Valcheva
Technik-/Wissenschafts-/F&E-Leiter bei GH RESEARCH PLC
Profil
Velichka Valcheva is currently working as the Chief Medical Officer at GH Research Plc.
Previously, she worked as the VP & Head-International Medical Affairs at Albireo Pharma, Inc. She holds a doctorate degree from the Medical University of Plovdiv and a graduate degree from Trinity College Dublin.
Aktive Positionen von Villy Valcheva
| Unternehmen | Position | Beginn |
|---|---|---|
| GH RESEARCH PLC | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Villy Valcheva
| Unternehmen | Position | Ende |
|---|---|---|
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | - |
Ausbildung von Villy Valcheva
| Trinity College Dublin | Graduate Degree |
| Medical University of Plovdiv | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GH RESEARCH PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
